{"article_title": "Cardinal Health closes $1.1 billion takeover of Harvard Drug Group", "article_keywords": ["billion", "closes", "group", "takeover", "supply", "generic", "million", "drug", "450", "harvard", "health", "11", "cardinal", "distribution", "market"], "article_url": "http://www.healthcarefinancenews.com/news/cardinal-health-closes-11-billion-takeover-harvard-drug-group", "article_text": "Photo of Cardinal Health from centralohioabc.org\n\nPublic supply chain giant Cardinal Health said it has wrapped up its acquisition of the Harvard Drug Group for more than $1.1 billion in cash from previous owner Court Square Capital Partners.\n\nHarvard Drug Group mainly distributes generic pharmaceuticals and pulled in more than $450 million in revenue in fiscal 2014. It employs 450 workers and manages two distribution facilities.\n\n[Also: Tracking 2015 mergers and acquisitions]\n\nAccording to Cardinal, one of the largest medical supply companies, the deal not only boosts its business for generic drug distribution, but also expands its telesales programs and packaging options.\n\nCardinal Health has come under fire for its size, recently settling charges with the Federal Trade Commission that it monopolized the market for low-energy radiopharmaceuticals in many metro areas. Cardinal will pay nearly $27 million to settle that case.\n\nDublin, Ohio-based Cardinal currently has a market capitalization of $28 billion.\n\nTwitter: @HenryPowderly", "article_metadata": {"og": {"url": "http://www.healthcarefinancenews.com/news/cardinal-health-closes-11-billion-takeover-harvard-drug-group", "image": "http://www.healthcarefinancenews.com/sites/healthcarefinancenews.com/files/Cardinal-Health-centralohioabc.org-feature_0.gif", "site_name": "Healthcare Finance News", "description": "Harvard Drug Group mainly distributes generic pharmaceuticals and pulled in more than $450 million in revenue in fiscal 2014.", "title": "Cardinal Health closes $1.1 billion takeover of Harvard Drug Group"}, "twitter": {"image": {"src": "http://www.healthcarefinancenews.com/sites/healthcarefinancenews.com/files/Cardinal-Health-centralohioabc.org-feature_0.gif"}, "description": "Harvard Drug Group mainly distributes generic pharmaceuticals and pulled in more than $450 million in revenue in fiscal 2014.", "site": "@HC_Finance", "card": "summary_large_image", "title": "Cardinal Health closes $1.1 billion takeover of Harvard Drug Group"}, "generator": "Drupal 7 (http://drupal.org)", "description": "Public supply chain giant Cardinal Health said it has wrapped up its acquisition of the Harvard Drug Group for more than $1.1 billion in cash from previous owner Court Square Capital Partners.&#13; Harvard Drug Group mainly distributes generic pharmaceuticals and pulled in more than $450 million in revenue in fiscal 2014. It employs 450 workers and manages two distribution facilities.", "viewport": "width=device-width; initial-scale=1.0; maximum-scale=1.0; user-scalable=no"}, "_id": "\"57477af46914bd0286fe2aac\"", "article_summary": "Photo of Cardinal Health from centralohioabc.orgPublic supply chain giant Cardinal Health said it has wrapped up its acquisition of the Harvard Drug Group for more than $1.1 billion in cash from previous owner Court Square Capital Partners.\nHarvard Drug Group mainly distributes generic pharmaceuticals and pulled in more than $450 million in revenue in fiscal 2014.\nCardinal Health has come under fire for its size, recently settling charges with the Federal Trade Commission that it monopolized the market for low-energy radiopharmaceuticals in many metro areas.\n[Also: Tracking 2015 mergers and acquisitions]According to Cardinal, one of the largest medical supply companies, the deal not only boosts its business for generic drug distribution, but also expands its telesales programs and packaging options.\nDublin, Ohio-based Cardinal currently has a market capitalization of $28 billion."}